MRK vs PFE — stock comparison
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, PFE grades highest (B 61). Not investment advice.
1-year price performance — higher line = stronger return
■ MRK +79.0%■ PFE +32.5%Past year, rebased to 100
| MRK | PFE | |
|---|---|---|
| Traddx grade | D (47) | B (61) |
| Price | $149.52 | $30.52 |
| Today | 2.18% | 1.90% |
| P/E | 82.20 | 19.60 |
| Net margin | 7.00% | 14.60% |
| Revenue (TTM) | $65,975.00M | $60,792.00M |
| Debt / equity | — | 1.36 |
| 52-week high | $156.92 | $30.67 |
| 52-week low | $82.01 | $23.62 |
Green = the strongest figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open MRK live → Open PFE live →